Changes of laminin beta 2 chain expression in congenital muscular dystrophy

被引:32
|
作者
Cohn, RD [1 ]
Herrmann, R [1 ]
Wewer, UM [1 ]
Voit, T [1 ]
机构
[1] UNIV COPENHAGEN,INST MOL PATHOL,COPENHAGEN,DENMARK
关键词
congenital muscular dystrophy; laminin; extracellular matrix; Walker-Warburg syndrome; immunohistochemistry;
D O I
10.1016/S0960-8966(97)00072-2
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
We studied the distribution of laminin beta 2 chain in the skeletal muscle basement membrane of 16 patients with congenital muscular dystrophy (CMD) by immunohistochemistry. A dramatic reduction in the laminin beta 2 staining was observed in four patients with classical merosin-negative CMD. A moderate reduction of laminin beta 2 labelling was observed in four patients with partial merosin deficiency and two patients with merosin-positive CMD. Two patients with merosin-positive CMD had no apparent changes in the expression of laminin beta 2. In three patients and one fetus diagnosed as Walker-Warburg syndrome (WWS) the laminin beta 2 pattern was similar to normal controls. We conclude that a primary deficiency in the laminin alpha 2 chain may lead to a vast or moderate reduction in the laminin beta 2 chain in the skeletal muscle membrane. (C) 1997 Elsevier Science B.V.
引用
收藏
页码:373 / 378
页数:6
相关论文
共 50 条
  • [11] Laminin α2 deficient congenital muscular dystrophy:: prenatal diagnosis
    Nass, D
    Goldberg, I
    Sadeh, M
    EARLY HUMAN DEVELOPMENT, 1999, 55 (01) : 19 - 24
  • [12] Congenital muscular dystrophy with partial laminin α2 chain (merosin) deficiency:: Immunocytochemical and molecular studies
    Tomé, FMS
    He, Y
    Chevallay, M
    Nicolas, V
    Cruaud, C
    Hori, H
    Mizuta, T
    Estournet, B
    Barois, A
    Fardeau, M
    Guicheney, P
    NEUROLOGY, 1998, 50 (04) : A187 - A187
  • [13] Novel laminin alpha 2 mutations in congenital muscular dystrophy
    Mendell, JT
    Feng, B
    Sahenk, Z
    Marzluf, GA
    Amato, AA
    Mendell, JR
    NEUROLOGY, 1997, 48 (03) : 3135 - 3135
  • [14] Mild congenital muscular dystrophy in two patients with an internally deleted laminin alpha 2-chain
    Allamand, V
    Sunada, Y
    Salih, MAM
    Straub, V
    Ozo, CO
    AlTuraiki, MHS
    Akbar, M
    Kolo, T
    Colognato, H
    Zhang, X
    Sorokin, LM
    Yurchenco, PD
    Tryggvason, K
    Campbell, KP
    HUMAN MOLECULAR GENETICS, 1997, 6 (05) : 747 - 752
  • [15] Expression of laminin chains in skin in merosin-deficient congenital muscular dystrophy
    Sewry, CA
    DAlessandro, M
    Wilson, LA
    Sorokin, LM
    Naom, I
    Bruno, S
    Ferlini, A
    Dubowitz, V
    Muntoni, F
    NEUROPEDIATRICS, 1997, 28 (04) : 217 - 222
  • [16] Defects in laminin-α2 expression are associated with cardiomyopathy in murine models for congenital muscular dystrophy.
    Mack, GK
    Rash, SM
    Pantely, GA
    Pang, J
    Sahn, DJ
    Pillers, DM
    AMERICAN JOURNAL OF HUMAN GENETICS, 2000, 67 (04) : 377 - 377
  • [17] Localization of laminin chains in the human retina: Possible implications for congenital muscular dystrophy associated with alpha 2-chain of laminin deficiency
    Toti, P
    DeFelice, C
    Malandrini, A
    Megha, T
    Cardone, C
    Villanova, M
    NEUROMUSCULAR DISORDERS, 1997, 7 (01) : 21 - 25
  • [18] Structure of the human laminin alpha 2-chain gene (LAMA2), which is affected in congenital muscular dystrophy
    Zhang, X
    Vuolteenaho, R
    Tryggvason, K
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (44) : 27664 - 27669
  • [19] Bortezomib Partially Improves Laminin α2 Chain-Deficient Muscular Dystrophy
    Korner, Zandra
    Fontes-Oliveira, Cibely C.
    Holmberg, Johan
    Carmignac, Virginie
    Durbeej, Madeleine
    AMERICAN JOURNAL OF PATHOLOGY, 2014, 184 (05): : 1518 - 1528
  • [20] Prenatal diagnosis in laminin α2 chain (merosin)-deficient congenital muscular dystrophy:: A collective experience of five international centers
    Vainzof, M
    Richard, P
    Herrmann, R
    Jimenez-Mallebrera, C
    Talim, B
    Yamamoto, LU
    Ledeuil, C
    Mein, R
    Abbs, S
    Brockington, M
    Romero, NB
    Zatz, M
    Topaloglu, H
    Voit, T
    Sewry, C
    Muntoni, F
    Guicheney, P
    Tomé, FMS
    NEUROMUSCULAR DISORDERS, 2005, 15 (9-10) : 588 - 594